As vaccines continue to roll out globally, wealthier nations have been inoculating their populations at much higher rate than the global South, sparking the debate over “vaccine passports.” Northwestern University professor Steven Thrasher, instead, argues in favor of focusing on…
By PBS NewsHour
The new target of 40 million doses by the end of March is still only half what the British-Swedish company had originally aimed for, triggering a spat between AstraZeneca and the EU last week.
By Associated Press
The country's drugs regulator gave emergency authorization for the vaccine developed by Oxford University and U.K.-based drugmaker AstraZeneca, and another developed by the Indian company Bharat Biotech.
By Aniruddha Ghosal, Sheikh Saaliq, Associated Press
Around 800,000 doses of the vaccine are expected to be in place for the start of the immunization program on Tuesday, which will be the country's biggest ever and which is being closely watched all around the world. British Health…
By Pan Pylas, Associated Press
In other news Tuesday, Senate Democrats failed in their second attempt to end a Republican filibuster and bring financial reform legislation to the floor. Also, an oil leak off the coast of Louisiana continued to spread as the Coast Guard…
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.